Table 2.
Year | |||||
---|---|---|---|---|---|
2003 | 2004 | 2005 | 2006 | 2007† | |
In-patients (number) | 11,912,797 | 11,205,770 | 11,269,412 | 11,978,011 | 12,244,671 |
PCCL (percentage) | |||||
0 | 56.45 | 52.25 | 52.75 | 53.64 | 55.16 |
1 | 0.62 | 0.60 | 0.52 | 0.80 | 1.41 |
2 | 14.73 | 15.07 | 13.83 | 13.40 | 14.35 |
3 | 16.67 | 17.75 | 17.51 | 17.59 | 17.69 |
4 | 11.52 | 14.33 | 15.40 | 14.56 | 11.39 |
Sex (percentage) | |||||
Male | 45.40 | 45.33 | 45.65 | 45.95 | 45.96 |
Female | 54.60 | 54.66 | 54.34 | 54.04 | 54.04 |
Age group (percentage) | |||||
<18 | 13.38 | 12.97 | 12.60 | 12.08 | 11.88 |
18 to 59 | 39.43 | 37.84 | 37.44 | 36.92 | 36.62 |
60 to 79 | 35.61 | 36.45 | 36.69 | 36.93 | 36.86 |
>79 | 19.84 | 21.65 | 22.41 | 23.52 | 24.13 |
Length of stay | |||||
Mean (days) | 7.31 | 7.51 | 7.29 | 7.35 | 7.26 |
Stdev (days) | 3.15 | 3.16 | 3.03 | 3.05 | 3.03 |
Characteristics of in-patients with a normal length of stay. PCCL is the patient clinical complexity level, a comorbidity measure used within the G-DRGs (0 = no complications or comorbidities, 4 = catastrophic complications or comorbidities). The figures published per DRG were weighted with the number of in-patients per DRG.
†The study sample for 2007 included only 1,964,313 in-patients with information on diagnoses.